Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, et al.
ACR Open Rheumatology
|
February 11, 2021
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, et al.
Rheumatology Advances in Practice
|
June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey
Eugenia Yupei Chock, Michael Putman, Richard Conway, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
The Journal of Investigative Dermatology
|
May 23, 2022
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
Thomas K Le, Isabelle Brown, Rebecca Goldberg, et al.
Journal of Translational Medicine
|
March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Shuming Chen, Tracee L McMiller, Abha Soni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events
Jarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
The Oncologist
|
July 27, 2024
Immune-related encephalitis after immune checkpoint inhibitor therapy
Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, et al.
ACR Open Rheumatology
|
February 11, 2021
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, et al.
Rheumatology Advances in Practice
|
June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey
Eugenia Yupei Chock, Michael Putman, Richard Conway, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
The Journal of Investigative Dermatology
|
May 23, 2022
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
Thomas K Le, Isabelle Brown, Rebecca Goldberg, et al.
Journal of Translational Medicine
|
March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Shuming Chen, Tracee L McMiller, Abha Soni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events
Jarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
The Oncologist
|
July 27, 2024
Immune-related encephalitis after immune checkpoint inhibitor therapy
Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, et al.
Page
of 6